EXPRS2 in a Range? Expres2ion Biotech Holding - Short Term - We look to Sell at 25.70 (stop at 27.50)
Trading within a Bearish Channel formation. Closed below the 20-day EMA. The primary trend remains bearish. We expect prices to stall close to our bespoke level (26.50). Further downside is expected although we pre
−2.120SEK
−95.99 MSEK
51.39 M
About EXPRES2ION BIOTECH HOLDING AB
Sector
Industry
CEO
Bent U. Frandsen
Website
Headquarters
Hørsholm
Founded
2010
ISIN
SE0008348262
FIGI
BBG00D3JNGY8
Expres2ion Biotech Holding AB engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer. Its products and services include custom made proteins and reagents; transfection reagent; process development; feasibility studies; and licensing. The company was founded by Charlotte Dyring, Wian de Jongh, and Martin Roland Jensen in 2010 and is headquartered in Hørsholm, Denmark.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of EXPRS2 is 2.720 SEK — it has increased by 6.67% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange EXPRES2ION BIOTECH HOLDING AB stocks are traded under the ticker EXPRS2.
EXPRS2 stock is 17.80% volatile and has beta coefficient of −0.47. Check out the list of the most volatile stocks — is EXPRES2ION BIOTECH HOLDING AB there?
Yes, you can track EXPRES2ION BIOTECH HOLDING AB financials in yearly and quarterly reports right on TradingView.
EXPRS2 stock has risen by 22.25% compared to the previous week, the month change is a 6.67% rise, over the last year EXPRES2ION BIOTECH HOLDING AB has showed a 49.35% decrease.
EXPRS2 net income for the last quarter is −17.82 M SEK, while the quarter before that showed −21.83 M SEK of net income which accounts for 18.37% change. Track more EXPRES2ION BIOTECH HOLDING AB financial stats to get the full picture.
Today EXPRES2ION BIOTECH HOLDING AB has the market capitalization of 131.08 M, it has decreased by 9.84% over the last week.
No, EXPRS2 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EXPRS2 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXPRES2ION BIOTECH HOLDING AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So EXPRES2ION BIOTECH HOLDING AB technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating EXPRES2ION BIOTECH HOLDING AB stock shows the sell signal. See more of EXPRES2ION BIOTECH HOLDING AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.